Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/19/2026 | Q4 | $306.2M | -- | -- | $0.68 | -- |
| 10/30/2025 | Q3 | $261.9M | $314M | $0.33 | $0.41 | -$0.09 |
| 07/31/2025 | Q2 | $241.7M | $302M | $0.14 | $0.25 | -$0.11 |
| 04/24/2025 | Q1 | $240.1M | $266M | $0.38 | $0.23 | $0.14 |
| 02/20/2025 | Q4 | $259.3M | $298M | $0.16 | $0.26 | -$0.10 |
| 10/24/2024 | Q3 | $302.8M | $307M | $0.17 | $0.41 | -$0.24 |
| 07/25/2024 | Q2 | $289.6M | $299M | -$0.72 | $0.40 | -$1.12 |
| 04/25/2024 | Q1 | $299.8M | $284M | $0.45 | $0.42 | $0.03 |
| 02/22/2024 | Q4 | $276M | $293M | $0.38 | $0.28 | $0.10 |
| 11/09/2023 | Q3 | -- | $271M | -$0.98 | -- | -- |
| 07/27/2023 | Q2 | -- | $276M | $0.27 | -- | -- |
| 04/27/2023 | Q1 | -- | $253M | $0.31 | -- | -- |
| 12/31/2022 | Q4 | -- | $242M | -$1.34 | -- | -- |
| 09/30/2022 | Q3 | -- | $232M | $0.28 | -- | -- |
| 06/30/2022 | Q2 | -- | $221M | $0.34 | -- | -- |
| 03/31/2022 | Q1 | -- | $207M | $0.28 | -- | -- |
| 12/31/2021 | Q4 | -- | $222M | $0.25 | -- | -- |
| 09/30/2021 | Q3 | -- | $187M | $0.15 | -- | -- |
| 06/30/2021 | Q2 | -- | $201M | $0.40 | -- | -- |
| 03/31/2021 | Q1 | -- | $180M | $0.51 | -- | -- |
| 12/31/2020 | Q4 | -- | $185M | -$0.09 | -- | -- |
| 09/30/2020 | Q3 | -- | $159M | $0.05 | -- | -- |
| 06/30/2020 | Q2 | -- | $150M | $0.10 | -- | -- |
| 03/31/2020 | Q1 | -- | $153M | -$1.11 | -- | -- |
| 12/31/2019 | Q4 | -- | $133M | -$0.38 | -- | -- |
| 09/30/2019 | Q3 | -- | $199M | $0.30 | -- | -- |
| 06/30/2019 | Q2 | -- | $215M | $0.50 | -- | -- |
| 03/31/2019 | Q1 | -- | $238M | $0.44 | -- | -- |
| 12/31/2018 | Q4 | -- | $236M | $0.16 | -- | -- |
| 09/30/2018 | Q3 | -- | $245M | $0.61 | -- | -- |
| 06/30/2018 | Q2 | -- | $268M | $0.45 | -- | -- |
| 03/31/2018 | Q1 | -- | $255M | $0.60 | -- | -- |
| 12/31/2017 | Q4 | -- | $265M | -$1.00 | -- | -- |
| 09/30/2017 | Q3 | -- | $275M | $0.35 | -- | -- |
| 06/30/2017 | Q2 | -- | $288M | $0.50 | -- | -- |
| 03/31/2017 | Q1 | -- | $265M | $0.55 | -- | -- |
| 12/31/2016 | Q4 | -- | $259M | $0.50 | -- | -- |
| 09/30/2016 | Q3 | -- | $268M | -$1.05 | -- | -- |
| 06/30/2016 | Q2 | -- | $274M | $0.40 | -- | -- |
| 03/31/2016 | Q1 | -- | $258M | $0.35 | -- | -- |
| 12/31/2015 | Q4 | -- | $248M | $0.25 | -- | -- |
Indivior PLC reported $314M worth of top line sales in its most recent quarter.
Indivior PLC announced earnings per share of $0.33 which represents a miss of analyst forecast a $0.41 per share.
Indivior PLC reported $252M that represents $1.95 per share over the last quarter.
Indivior PLC's earnings are forecast to grow from $0.02 per share to $1.62 per share next year representing an increase of 15404.73%.
Indivior PLC's next earnings date is February 19, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.